Suppr超能文献

North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis.

作者信息

Small K W

机构信息

Department of Ophthalmology, Jules Stein Eye Institute, University of California School of Medicine, Los Angeles, USA.

出版信息

Trans Am Ophthalmol Soc. 1998;96:925-61.

Abstract

PURPOSE

To study the North Carolina macular dystrophy phenotype (MCDR1) in multiple families of different ethnic backgrounds, to determine the genetic relationships of these families, and to determine the minimal candidate region of the MCDR1 gene.

METHODS

Thirteen families with the North Carolina MCDR1 were ascertained. These families were of various ethnic and geographic origins, such as Caucasian, Mayan Indian, African American, French, British, German, and American. Extensive genealogical investigations were performed for all families. A total of 232 members of these families underwent comprehensive ophthalmic examinations, including blood collection for genotyping. Of these, 117 were found to be affected with the disorder. Genetic linkage simulation studies were performed using the computer program SIMLINK. Two-point linkage analysis, haplotype analysis, and multipoint linkage analyses were performed using the computer programs M-LINK, VITESSE, and FASTLINK.

RESULTS

The clinical features were consistent with the diagnosis of North Carolina macular dystrophy in all families studied. Multipoint linkage analysis and haplotype analysis indicate that the MCDR1 gene is in the 1.1-centimorgan (cM) interval between the genetic markers D6D249 and D6S1671, with a maximum LOD score of 40.03. There was no evidence of genetic heterogeneity. Families 765, 768, 772, 1193, and 1292 shared the same chromosomal haplotype in this region, suggesting they are the result of the same ancestral mutation. The remaining families each likely represent independent origins of the mutation in the MCDR1 gene. North Carolina macular dystrophy is present worldwide and does not emanate from a single founder from North Carolina.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4088/1298417/5e130632f52f/taos00003-0944-a.jpg

相似文献

3
A North Carolina macular dystrophy phenotype in a Belizean family maps to the MCDR1 locus.
Am J Ophthalmol. 1998 Apr;125(4):502-8. doi: 10.1016/s0002-9394(99)80191-3.
7
Thirty-Year follow-up of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy).
Ophthalmology. 2011 Jul;118(7):1435-43. doi: 10.1016/j.ophtha.2010.10.041. Epub 2011 Feb 18.
8
North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2.
Ophthalmic Paediatr Genet. 1993 Dec;14(4):143-50. doi: 10.3109/13816819309042913.

引用本文的文献

2
Maculopathies: A Systematic Literature Review on Pathophysiology, Public Health, and Treatment.
Cureus. 2024 Dec 1;16(12):e74911. doi: 10.7759/cureus.74911. eCollection 2024 Dec.
3
New Noncoding Base Pair Mutation at the Identical Locus as the Original NCMD/MCDR1 in a Mexican Family, Suggesting a Mutational Hotspot.
J Vitreoretin Dis. 2023 Jan 2;7(1):33-42. doi: 10.1177/24741264221129432. eCollection 2023 Jan-Feb.
4
Letter to the Editor Regarding: "Modern diagnostic and therapeutic approaches in familial maculopathy with reference to North Carolina macular dystrophy" by Jana Nekolova et al.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Mar;167(1):95-97. doi: 10.5507/bp.2023.003. Epub 2023 Jan 17.
5
Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy.
Am J Hum Genet. 2022 Nov 3;109(11):2029-2048. doi: 10.1016/j.ajhg.2022.09.013. Epub 2022 Oct 14.
7
A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy.
Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):645-653. doi: 10.1007/s00417-021-05376-w. Epub 2021 Aug 24.
8
Modern diagnostic and therapeutic approaches in familial maculopathy with reference to North Carolina macular dystrophy.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Dec;166(4):418-427. doi: 10.5507/bp.2021.037. Epub 2021 Jun 22.
10
Unilateral benign yellow dot maculopathy.
Am J Ophthalmol Case Rep. 2021 Mar 11;22:101068. doi: 10.1016/j.ajoc.2021.101068. eCollection 2021 Jun.

本文引用的文献

1
Clinical and genetic evidence for autosomal dominant North Carolina macular dystrophy in a German family.
Am J Ophthalmol. 1997 Sep;124(3):412-5. doi: 10.1016/s0002-9394(14)70842-6.
2
North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2.
Ophthalmic Paediatr Genet. 1993 Dec;14(4):143-50. doi: 10.3109/13816819309042913.
4
An inherited central retinal pigment epithelial dystrophy.
Birth Defects Orig Artic Ser. 1982;18(6):281-96.
5
Autosomal dominant central pigment epithelial and choroidal degeneration.
Ophthalmology. 1982 Dec;89(12):1407-13. doi: 10.1016/s0161-6420(82)34621-7.
6
Strategies for multilocus linkage analysis in humans.
Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443-6. doi: 10.1073/pnas.81.11.3443.
7
Central areolar pigment epithelial dystrophy.
Ophthalmologica. 1984;189(1-2):69-72. doi: 10.1159/000309388.
8
Hereditary macular degeneration and amino-aciduria.
Am J Ophthalmol. 1971 Jan;71(1 Pt 2):224-30. doi: 10.1016/0002-9394(71)90394-1.
9
A new dominant progressive foveal dystrophy.
Am J Ophthalmol. 1974 Dec;78(6):903-16. doi: 10.1016/0002-9394(74)90800-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验